You searched for metabolic diseases - Page 55 of 63

In Depth 17 Mar 2021

Feed Additives Put the Brakes on Cattle Methane Emissions

…one of several mechanisms, including inhibiting methane-producing bacteria or the protozoans that live in synergy with them, or boosting the metabolic pathways involved in using the hydrogen that would otherwise…

March 17, 2021 - 8 minutesmins - By Sachin Rawat

The future of epilepsy treatment: pioneering advances and patient-centric care

Epilepsy, one of the most widespread neurological diseases in the world, characterized by recurrent seizures, affects approximately 50 million people globally. In Europe, up to six million people are estimated…

October 15, 2024 - 6 minutesmins - By External Contributor

News and Trends 17 Jan 2022

Swiss Startup Signs on with Novo Nordisk to Discover Obesity Treatments

…Under the joint project, EraCal and Novo Nordisk will research targets for obesity treatments by identifying molecules that can control appetite and improve metabolic health. The drugs will be screened…

January 17, 2022 - 3 minutesmins - By Dan Samorodnitsky

News and Trends 17 Jul 2018

Gene Therapy Could Prevent Deadly Brain Disease

An international research team used gene therapy to prevent Gaucher disease, a potentially deadly neurodegenerative condition, in mice. The approach could eventually be used to treat human diseases in the…

July 17, 2018 - 3 minutesmins - By Alexander Burik

News and Trends 6 Feb 2020

Valbiotis Teams up with Nestlé to Reduce Type 2 Diabetes Risk

…of Valbiotis. “Its global reach, strategic intent to develop science-based nutritional health solutions, and focus on fighting metabolic disorders like diabetes will be instrumental.” Valbiotis’ lead candidate food supplement is…

February 6, 2020 - 2 minutesmins - By Jonathan Smith

Optics11 Life receives €5 million in funding for drug development

News and Trends 18 Jul 2022

FORTY51 Ventures closes $43M biotech fund and announces first investment

…needs suffering from metabolic obstructive sleep apnea. The fund is advised by a complementary founding team of three industry veterans, Sara Núñez-García, Sascha Oliver Bucher and Tamás Schweighoffer, who the…

July 18, 2022 - 3 minutesmins - By Jim Cornall

In Depth 4 Sep 2023

The biggest private biotech investments in August 2023

The companies Genesis Therapeutics, ADARx Pharmaceuticals, and Abcuro bagged the biggest biotech investments in August 2023. Around the world, companies focused on immunology, genetic disorders, and metabolic disorders attracted the…

September 4, 2023 - 3 minutesmins - By Willow Shah-Neville

News and Trends 18 Dec 2018

Gut Bacteria Could Combat Obesity and Depression

…in this study gave a fecal transplant of healthy subjects to patients with the metabolic syndrome. The study found that only patients with a specific gut microbiota profile benefitted from…

December 18, 2018 - 3 minutesmins - By Jonathan Smith

News and Trends 5 Sep 2019

Orchard’s Gene Therapy Improves Children’s Motor Ability

…a gene therapy intended to treat another neurometabolic syndrome called mucopolysaccharidosis type I (MPS-I). The company reported that the two patients treated so far have experienced a correction of the…

September 5, 2019 - 3 minutesmins - By Clara Rodríguez Fernández

News and Trends 19 May 2022

Evotec, Sernova in partnership to develop beta cell diabetes therapy

…lost beta cells has long been a focus for diabetes research. In 2010, Evotec acquired DeveloGen, a metabolic disease company and spinout from the Max-Planck Institute in Germany that had…

May 19, 2022 - 3 minutesmins - By Susannah Rodgers

In Depth 14 Feb 2024

The next leap in pet health: longevity drugs for dogs

…dogs’ metabolic health to delay the onset and reduce the impact of age-associated diseases. “It’s a little bit more of a reversal mechanism. It’s not going to make a 10-year-old…

February 14, 2024 - 7 minutesmins - By Willow Shah-Neville

News and Trends 12 Feb 2018

Healthcare-Biotech Partnership Pledges to Take its Type 2 Diabetes Treatment Worldwide

Swiss pharma Roivant has given French biotech Poxel €28M upfront to get involved with the development and commercialization of imeglimin, a new treatment for metabolic disorders like type 2 diabetes….

February 12, 2018 - 3 minutesmins - By Alex Dale

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: metabolic diseases

Feed Additives Put the Brakes on Cattle Methane Emissions

The future of epilepsy treatment: pioneering advances and patient-centric care

Swiss Startup Signs on with Novo Nordisk to Discover Obesity Treatments

Gene Therapy Could Prevent Deadly Brain Disease

Valbiotis Teams up with Nestlé to Reduce Type 2 Diabetes Risk

FORTY51 Ventures closes $43M biotech fund and announces first investment

The biggest private biotech investments in August 2023

Gut Bacteria Could Combat Obesity and Depression

Orchard’s Gene Therapy Improves Children’s Motor Ability

Evotec, Sernova in partnership to develop beta cell diabetes therapy

The next leap in pet health: longevity drugs for dogs

Healthcare-Biotech Partnership Pledges to Take its Type 2 Diabetes Treatment Worldwide

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!